Email pagePDF viewPrint viewRSS News FeedsEmail Alert

Insider Transactions

Email pagePDF viewPrint viewRSS News FeedsEmail Alert
SUMMIT FINANCIAL GROUP, INC. (NASDAQ - SMMF)  
Click on an individual's name to see their transaction history.

Insider Transaction Activity (Last 6 Months)
Aggregates Shares Price ($) Value ($)
Open Market Buys34,40822.82785,070
Open Market Sells (31,374) 26.41 (828,525)
Options Ex. & Sold39,88014.36572,586
Net Shares31,90921.29233,169

High Volume Traders (Last 6 Months)
Name # Buys # Sells # Options Ex. & Sold Total # Trans. Net Shares
Gary L. Hinkle12001233,001
H. Charles Maddy III03477,771
Thomas J. Hawse III0606 (6,000)
Oscar M. Bean0202 (4,100)
Robert S. Tissue02574,001


Transaction Date Name Action Shares Price($) Value($) Type Report Date
12/6/2017H. Charles Maddy III
Vice Chairman, Chief Executive Officer & President
Sell (6,169) 27.14 (167,427) Direct12/8/2017
 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
12/6/2017H. Charles Maddy III
Vice Chairman, Chief Executive Officer & President
Buy7,77112.0193,330Direct12/8/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/6/2017H. Charles Maddy III
Vice Chairman, Chief Executive Officer & President
Buy6,16912.0174,090Direct12/8/2017
 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/6/2017Markwood, Julie R.
Chief Accounting Officer and Vice President
Buy1,96312.0123,576Direct12/8/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/6/2017Markwood, Julie R.
Chief Accounting Officer and Vice President
Sell (1,559) 27.14 (42,311) Direct12/8/2017
 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
12/6/2017Markwood, Julie R.
Chief Accounting Officer and Vice President
Buy1,55912.0118,724Direct12/8/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/6/2017Robert S. Tissue
Senior VP & CFO
Buy4,00112.0148,052Direct12/8/2017
 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/6/2017Robert S. Tissue
Senior VP & CFO
Buy3,17712.0138,156Direct12/8/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/6/2017Robert S. Tissue
Senior VP & CFO
Sell (3,177) 27.14 (86,224) Direct12/8/2017
 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
12/4/2017Scott C. Jennings
COO & Senior VP
Sell (2,234) 27.00 (60,318) Direct12/5/2017
  Open market or private sale of non-derivative or derivative security
12/4/2017Patrick N. Frye
Chief of Credit Administration & Senior VP
Buy8809.498,351Direct12/5/2017
 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/4/2017Patrick N. Frye
Chief of Credit Administration & Senior VP
Buy1,20017.7921,348Direct12/5/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/4/2017Patrick N. Frye
Chief of Credit Administration & Senior VP
Sell (3,680) 27.50 (101,200) Direct12/5/2017
 Open market or private sale of non-derivative or derivative security
12/4/2017Patrick N. Frye
Chief of Credit Administration & Senior VP
Buy1,60025.9341,488Direct12/5/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/1/2017Scott C. Jennings
COO & Senior VP
Buy8809.498,351Direct12/5/2017
 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/1/2017Scott C. Jennings
COO & Senior VP
Buy1,40017.7924,906Direct12/5/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/1/2017Scott C. Jennings
COO & Senior VP
Buy1,60025.9341,488Direct12/5/2017
 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
12/1/2017Scott C. Jennings
COO & Senior VP
Sell (1,646) 27.00 (44,442) Direct12/5/2017
  Open market or private sale of non-derivative or derivative security
11/29/2017H. Charles Maddy III
Vice Chairman, Chief Executive Officer & President
Sell (3,473) 27.25 (94,639) Direct11/30/2017
 Open market or private sale of non-derivative or derivative security
11/28/2017H. Charles Maddy III
Vice Chairman, Chief Executive Officer & President
Sell (327) 27.25 (8,911) Direct11/30/2017
  Open market or private sale of non-derivative or derivative security
11/27/2017Dewey F. Bensenhaver
Director
Sell (2,246) 26.85 (60,298) Direct12/4/2017
 Open market or private sale of non-derivative or derivative security
11/16/2017Dewey F. Bensenhaver
Director
Sell (763) 26.16 (19,961) Indirect12/4/2017
  Open market or private sale of non-derivative or derivative security
11/14/2017Gary L. Hinkle
Director
Buy1,29325.1232,475Direct11/14/2017
 Open market or private purchase of non-derivative or derivative security
11/13/2017Gary L. Hinkle
Director
Buy1,70825.1042,866Direct11/14/2017
  Open market or private purchase of non-derivative or derivative security
11/7/2017Gary L. Hinkle
Director
Buy2,33026.5261,789Direct11/7/2017
 Open market or private purchase of non-derivative or derivative security
11/3/2017Gary L. Hinkle
Director
Buy40026.9610,785Direct11/6/2017
  Open market or private purchase of non-derivative or derivative security
11/3/2017Gary L. Hinkle
Director
Buy14027.003,780Direct11/6/2017
 Open market or private purchase of non-derivative or derivative security
11/2/2017Robert S. Tissue
Senior VP & CFO
Buy8809.498,351Direct11/6/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
11/2/2017Robert S. Tissue
Senior VP & CFO
Buy1,40017.7924,906Direct11/6/2017
 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
11/2/2017Robert S. Tissue
Senior VP & CFO
Buy1,60025.9341,488Direct11/6/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
11/2/2017Robert S. Tissue
Senior VP & CFO
Sell (3,880) 27.50 (106,700) Direct11/6/2017
 Open market or private sale of non-derivative or derivative security
11/2/2017Gary L. Hinkle
Director
Buy2,13026.9457,391Direct11/2/2017
  Open market or private purchase of non-derivative or derivative security
11/2/2017Thomas J. Hawse III
Director
Sell (100) 27.31 (2,731) Direct11/2/2017
 Open market or private sale of non-derivative or derivative security
11/2/2017Thomas J. Hawse III
Director
Sell (400) 27.35 (10,940) Direct11/2/2017
  Open market or private sale of non-derivative or derivative security
11/1/2017H. Charles Maddy III
Vice Chairman, Chief Executive Officer & President
Buy1,4009.4913,286Direct11/3/2017
 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
11/1/2017H. Charles Maddy III
Vice Chairman, Chief Executive Officer & President
Buy2,40017.7942,696Direct11/3/2017
  Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
11/1/2017Thomas J. Hawse III
Director
Sell (1,000) 27.28 (27,280) Direct11/2/2017
 Open market or private sale of non-derivative or derivative security
11/1/2017Thomas J. Hawse III
Director
Sell (500) 27.55 (13,775) Direct11/2/2017
  Open market or private sale of non-derivative or derivative security
10/31/2017Thomas J. Hawse III
Director
Sell (1,000) 27.29 (27,290) Direct11/2/2017
 Open market or private sale of non-derivative or derivative security
10/31/2017Oscar M. Bean
Chairman
Sell (4,000) 27.01 (108,040) Direct11/1/2017
  Open market or private sale of non-derivative or derivative security
 1 2 3 4 5 ...

Copyright 2017, © S&P Global Market Intelligence  Terms of Use